Molecular Diagnostics for Everyone
The World’s First Low‑Cost, High‑Throughput,
Near-Patient Molecular Diagnostic Test System
The World’s first Low-Cost, High‑Throughput,
Near-Patient Molecular Diagnostic Test System
Fast MDx is a Social Enterprise which provides molecular diagnostic testing
that will benefit society and have less impact on the environment
We align with the UK’s National Health Service commitment to delivering a Net Zero NHS by 2040
And with almost half of the World’s population having little or no access to diagnostics,
our goal is to provide affordable molecular diagnostics in more countries and in more settings
Low Cost Testing...
No CapEx as the Fast MDx platform is lent as part of the low cost test contract
No packaging cost
No transportation costs
No Biosecure lab overheads
Single technician operation
Ultra-Fast Fully Automated Results...
Faster Results
Earlier treatment
Better outcomes
Reduced spread of infectious disease
Near-Patient High- Throughput Testing...
1000+ Patient
test results per 8 hour shift
5 times more efficent than manual test processing
Lowest Carbon Footprint...
Near-Patient
eliminates transportation
and packaging
The Ultra-Fast
NGx2 4-Channel qPCR
thermal cycle minimizes
electrical use
Fully automated
optimized sample processing reduces
handling errors and the need to retest
Low Cost Testing
Ultra-Fast Fully Automated Results
No CapEx as the Fast MDx platform is lent as part of the low cost test contract
No packaging cost
No transportation costs
No Biosecure lab overheads
Single technician operation
Faster Results
Earlier treatment
Better outcomes
Reduced spread of infectious disease
Lowest Carbon Footprint
Near-Patient High- Throughput Testing
1000+ Patient
test results per 8 hour shift
5 times more efficient than manual test processing
Near-Patient
eliminates transportation
and packaging
The Ultra-Fast
NGx2 4-Channel qPCR
thermal cycle minimizes
electrical use
Fully automated
optimized sample processing reduces
handling errors and the need to retest
PRECISION
TESTING
HIGH-
THROUGHPUT
LOW COST
GREENER
TESTING
ULTRA-FAST
RESULTS
A new coalition of industry and health charities, led by former Health Minister, raise the alarm over missed opportunities to tackle Antimicrobial Resistance in the UK.
Fast MDx was delighted to read an excellent article in Genome Web by Justin Petrone, that explains how the platform is being validated by Public Health Wales, which will complete Fast MDx’s UKCA and CE-IVDr regulatory approvals program.
Cervical cancer kills over one third of a million women around the World every year. These deaths can be prevented through a program of vaccination and molecular diagnostic testing.
Canada is currently grappling with a severe shortage of skilled healthcare professionals, particularly in the fields of medical laboratory technology (MLT) and radiology technology (RT). Fast MDx's high-throughput testing can help to ease this situation.